8-K: 22nd Century Group Amends Preferred Stock, Warrants

22nd Century Group, Inc. has amended its Series A Convertible Preferred Stock and Warrants, extending the stockholder approval deadline and modifying conversion and ATM facility terms.

Summary

• The Stockholder Approval Deadline has been extended to February 23, 2026.
• The Company will seek Stockholder Approval to effect a reverse stock split to comply with Nasdaq Listing Rules.
• The Company will seek Stockholder Approval to approve an offering of its securities, including preferred stock and warrants on substantially the same terms, up to $20 million.
• Prior to the Stockholder Approval Deadline, the Company may only sell shares under its ATM Facility at a price per share equal to at least $2.00, and with no restrictions after obtaining Stockholder Approval.
• If Stockholder Approval is not obtained by the deadline, the Company may not sell shares under the ATM Facility until such approval is secured.
• Subject to Stockholder Approval, the Company's Board may reduce the Conversion Price of the Preferred Stock.
• Subject to Stockholder Approval, an alternative conversion feature for the Preferred Stock allows conversion at 85% of the lowest VWAP in any of the twenty trading days preceding the conversion.
• Subject to Stockholder Approval, certain anti-dilution adjustments will be provided to the exercise price of the Warrants to protect against future dilutive issuances.
• The Investors have waived any breaches related to the Company's failure to obtain Stockholder Approval by the initial deadline.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to the failure to meet the initial stockholder approval deadline and the necessity of a reverse stock split, which signals underlying challenges. However, the successful negotiation of a waiver and the potential for future capital raise provide some mitigating positive aspects, preventing a severely negative score.

Positives

• The Company secured a waiver from investors for its failure to obtain Stockholder Approval by the initial deadline, avoiding immediate default consequences.
• The extension of the Stockholder Approval Deadline to February 23, 2026, provides additional time to secure necessary approvals.
• The potential for a new offering of securities up to $20 million, if approved by stockholders, could provide additional capital.
• The ability to voluntarily adjust the Conversion Price of Preferred Stock (subject to approval) offers flexibility for future capital structure management.

Negatives

• The Company failed to obtain Stockholder Approval by the initial deadline, indicating potential challenges in shareholder consensus or operational execution.
• The need to seek Stockholder Approval for a reverse stock split suggests the Company's common stock price may be below Nasdaq's minimum bid price requirement, posing a delisting risk.
• Restrictions on the ATM Facility, including a minimum price of $2.00 per share and a halt if stockholder approval is not met, could limit liquidity and capital access.
• If Stockholder Approval is not obtained by February 23, 2026, Preferred Stock holders may require the Company to redeem their shares in cash at 100% of the Stated Value, creating a potential cash outflow obligation.

Risks

• Failure to obtain Stockholder Approval by February 23, 2026, could trigger redemption rights for Preferred Stock holders, requiring significant cash outlays.
• The Company faces the risk of delisting from Nasdaq if it fails to effect a reverse stock split and maintain compliance with listing rules.
• Future equity issuances, including the proposed $20 million offering and warrant adjustments, could lead to significant dilution for existing common stockholders.
• Restrictions on the ATM Facility could hinder the Company's ability to raise capital efficiently if stockholder approval is delayed or not obtained.

Future Outlook

The Company plans to hold a stockholder meeting by February 23, 2026, to seek approval for a reverse stock split to maintain Nasdaq compliance, a new $20 million securities offering, and amendments to its preferred stock and warrants. Failure to obtain these approvals by the deadline could lead to preferred stock redemption demands.

Industry Context

This announcement is primarily company-specific, addressing internal financing and corporate governance matters. It does not directly relate to broader industry trends or competitive landscape shifts, but rather focuses on ensuring the company's financial flexibility and compliance with listing requirements.

Corporate Governance

Related Party Transactions

• The Omnibus Amendment and Waiver was entered into with the existing holders of the outstanding Series A Convertible Preferred Stock and warrants, who are significant stakeholders.

Stakeholder Impact

• **Shareholders:** Face potential dilution from future equity offerings and warrant adjustments. The proposed reverse stock split will reduce the number of outstanding shares, potentially increasing the per-share price but not necessarily the overall market capitalization. Failure to obtain stockholder approval could lead to significant redemption demands.
• **Preferred Stock Holders:** Benefit from the waiver of the Company's previous breach and the extended deadline. They gain an alternative conversion feature and the potential for a reduced conversion price. However, they also have the right to demand redemption if stockholder approval is not met by the new deadline.
• **Warrant Holders:** Will receive anti-dilution adjustments to their exercise price, subject to stockholder approval, providing protection against future dilutive issuances.
• **Creditors:** The potential for a $20 million capital raise could improve the Company's financial position, but the risk of preferred stock redemption if approvals are not met could strain liquidity.

Next Steps

• The Company will hold an annual or special meeting of stockholders on or prior to February 23, 2026, to obtain Stockholder Approval for the proposed changes.
• The Company will promptly file the Certificate of Amendment to the Certificate of Designations with the Secretary of State of the State of Nevada.
• If Stockholder Approval is not obtained by February 23, 2026, the Company must call a meeting every 120 days thereafter to seek approval until it is obtained or the warrants are no longer outstanding.

Key Dates

Recommendation

The company is addressing critical financing and listing compliance issues through these amendments. While the delay in obtaining initial stockholder approval and the need for a reverse stock split are concerning, the waiver of past breaches and the potential for a new capital raise provide some stability. The outcome of the upcoming stockholder vote on February 23, 2026, will be crucial in determining the company's immediate financial and operational trajectory, warranting a 'hold' position until further clarity emerges.

Keywords

Preferred Stock, Warrants, Stockholder Approval, Reverse Stock Split, Nasdaq Listing Rules, ATM Facility, Conversion Price, Anti-Dilution, Capital Raise, Omnibus Amendment